APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 68 filers reported holding APTOSE BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,000 | 0.0% | 4,437 | +12.7% | 0.00% | – |
| Q2 2022 | $2,000 | -75.0% | 3,936 | -34.7% | 0.00% | – |
| Q1 2022 | $8,000 | +300.0% | 6,032 | +239.6% | 0.00% | – |
| Q4 2021 | $2,000 | -97.1% | 1,776 | -91.4% | 0.00% | – |
| Q3 2021 | $70,000 | +6.1% | 20,732 | +4.0% | 0.00% | – |
| Q2 2021 | $66,000 | -84.4% | 19,931 | -71.9% | 0.00% | -100.0% |
| Q1 2021 | $423,000 | – | 70,863 | +264.4% | 0.00% | – |
| Q4 2020 | $0 | – | 19,446 | +311.9% | 0.00% | – |
| Q3 2020 | $0 | – | 4,721 | -15.5% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 5,585 | -80.8% | 0.00% | – |
| Q1 2020 | $173,000 | +311.9% | 29,153 | +44.7% | 0.00% | – |
| Q3 2019 | $42,000 | +40.0% | 20,151 | +73.4% | 0.00% | – |
| Q2 2019 | $30,000 | +650.0% | 11,621 | +438.0% | 0.00% | – |
| Q1 2019 | $4,000 | +300.0% | 2,160 | +127.8% | 0.00% | – |
| Q4 2018 | $1,000 | – | 948 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 2,900,000 | $12,702,000 | 3.02% |
| P.A.W. CAPITAL CORP | 750,000 | $3,285,000 | 2.90% |
| Prosight Management, LP | 824,795 | $3,613,000 | 1.67% |
| Voss Capital, LLC | 715,000 | $3,132,000 | 1.58% |
| DRW Securities, LLC | 7,976,176 | $34,936,000 | 1.23% |
| Ally Bridge Group (NY) LLC | 1,409,150 | $6,172,000 | 1.06% |
| Nantahala Capital Management | 7,272,673 | $31,854,000 | 0.99% |
| SANDERS MORRIS HARRIS LLC | 925,153 | $4,231,000 | 0.96% |
| PRECEPT MANAGEMENT LLC | 440,696 | $1,930,000 | 0.78% |
| Endurant Capital Management LP | 477,895 | $2,093,000 | 0.76% |